Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Vietnam flag Vietnam · Delayed Price · Currency is VND
58,300
+200 (0.34%)
At close: Apr 28, 2026
9.38%
Market Cap 1.25T
Revenue (ttm) 481.09B
Net Income (ttm) 164.47B
Shares Out 21.50M
EPS (ttm) 7,650.02
PE Ratio 7.62
Forward PE n/a
Dividend 4,000.00 (6.88%)
Ex-Dividend Date Mar 20, 2026
Volume 6,449
Average Volume 7,882
Open 58,100
Previous Close 58,100
Day's Range 58,100 - 59,400
52-Week Range 47,000 - 65,900
Beta 0.47
RSI 59.97
Earnings Date Apr 17, 2026

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin... [Read more]

Industry Pharmaceutical Preparations
Founded 1962
Country Vietnam
Stock Exchange Hanoi Stock Exchange
Ticker Symbol DP3
Full Company Profile

Financial Performance

In 2025, HNX:DP3's revenue was 438.01 billion, an increase of 4.92% compared to the previous year's 417.49 billion. Earnings were 153.56 billion, an increase of 26.73%.

Financial Statements

News

There is no news available yet.